ONCY

Oncolytics Biotech Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↑ 5/10
Oncolytics Biotech sales and earnings growth
ONCY Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ -0.30%
Oncolytics Biotech gross and profit margin trends
ONCY Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 45010.83%
Oncolytics Biotech net debt vs free cash flow
ONCY Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Oncolytics Biotech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks